SME of the Week: April Roundup
Posted on
Every week, we put a spotlight on one of the DigitalHealth.London Accelerator or Launchpad companies. Here’s a roundup of this month’s featured SMEs:
About: getUBetter is an evidence-based, CE marked, digital self-management platform for all common musculoskeletal injuriesand conditions. We help organisations, such as CCG’s, to provide a digital first approach for their MSK pathways. Each element of the pathway is configured to the local health system and delivered to their population.
Recent success: We have recently extended our deployment in South West London to cover Kingston and our most recent contract covers the whole of Bristol, North Somerset and South Gloucester.
Ask: We are looking to connect with key MSK stakeholders across the country who are looking to provide digital self-management support to their population as part of their MSK pathway transformation work.
Contact: contact@getubetter.com
Learn more: https://digitalhealth.london/sme-of-the-week-getubetter/
About: Bleepa is a revolutionary medical imaging communications app, providing an easy-to-use, high-quality tool to enable remote and secure communications between frontline clinicians and teams. Bleepa has unparalleled functionality for everyday practice and can be accessed from any internet-connected device, enabling control of patient cases when on the go.
Recent success: First contract awarded on the NHSX clinical communications framework with the Royal Berkshire NHS Foundation Trust adopting Bleepa and its new features of the virtual multi-disciplinary team meetings module, photo capture of medical photographs such as wounds and skin lesions, and supporting the evaluation of the platform’s referral module. Find out more: https://digitalhealth.london/accelerator-company-bleepa-awarded-royal-berkshire-nhs-trust-contract/
Ask: Introductions to healthcare professionals and organisations keen to move away from using unregulated platforms for clinical communications and image sharing for discussion and diagnosis.
Contact: nick.mayhew@fbkmed.com
Learn more: https://www.youtube.com/watch?v=5o4ub4W-gqY
About: Every 6 minutes a person in the UK loses their sight. Imaging the retina can diagnose over 50 eye and whole body diseases, including glaucoma and diabetes. 22 patients a month lose their sight whilst waiting to be seen in an NHS outpatient clinic for their vision. Ophthalmology is the largest outpatient specialty in the NHS, with 7.9 million outpatient appointments occurring annually, of which 52% are assessed as unnecessary. This costs the NHS up to £495 million per year in wasted outpatient referrals.
At VUI Diagnostics our goal is to make retinal screening affordable, simpler and faster. We have created a system that blends an innovative retinal imaging device with a mobile image viewer and referral software.
The ViewEye device is a portable, hand-held device that takes retinal images without the need for mydriatic eye drops. Images can be taken by any level of trained health care professional – not necessarily a doctor. Images are transmitted to the companion smartphone app, providing high quality imaging for any clinician anywhere to review.
Our end-to-end offering enables clinicians in General Practice, Neurology, Endocrinology and Emergency Departments to have access to benchtop camera quality imaging in a portable, fully digitalised product solution improving the image acquisition and diagnostic process for the clinician resulting in improvements in quality of care for the patient.
Recent success: We recently finalised our ViewEye hardware and iOS software platform, in addition to hitting key development milestones on our VUI WebApp e-referral platform. We have also secured key grants and manufacturing partners which will allow us to scale our production capacity in preparation for market entry once regulatory approval has been achieved.
We have also recently completed an exploration of evaluation and research opportunities across London with clinical and academic partners.
Ask: We are looking for healthcare partners who would like to collaborate to pilot the VUI device in Primary Care, secondary care and with patient groups who find access to retinal screening services more difficult e.g. prisons, traveller communities, people who are homeless.
Contact: simonrabinowicz@vuidiagnostics.com (CEO), uddhavvaghela@vuidiagnostics.com (CTO)
Learn more: https://www.vuidiagnostics.com/
The DigitalHealth.London Accelerator is a collaborative programme funded by London’s three Academic Health Science Networks – UCL Partners, Imperial College Health Partners, and the Health Innovation Network, MedCity, CW+ and receives match funding from the European Regional Development Fund.
Related content
Bridging Gaps in Women’s Health: The Rise of FemTech Innovation
As innovations in FemTech continue to evolve, the future of women’s health holds promise for improved equity and accessibility. In this blog, Lavinia Pamparau, NHS Navigator for DigitalHealth.London, delves into how FemTech solutions tackle prevailing health disparities and empower women to proactively manage their health and well-being.
Getting FemTech into the NHS
FemTech has the potential to tackle health inequalities related to gender and improve the quality of life for millions of women in the UK. But, to achieve maximum impact, FemTech needs to be fully integrated into NHS pathways and services. In this blog, NHS Navigator for DigitalHealth.London Yasmin Stinchcombe explores how FemTech innovators can successfully engage with the NHS.
DigitalHealth.London Spotlight: Shahnawaz Asif Raja
Every week, we shine a spotlight on one of our DigitalHealth.London companies, founders, or NHS fellows. Today, we are excited to feature Shahnawaz Asif Raja, who is currently participating in the DigitalHealth.London Leap programme.
